The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 3, 1996, Pages 499-506

  Saward, Laura ^a   Zahradka, Peter ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

A10; Angiotensin II; AT1 receptor; AT2 receptor; Losartan; PD123319; Prostaglandins; RT PCR; Vascular smooth muscle

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; CONTRACTILE PROTEIN; DNA; INDOMETACIN; LOSARTAN; PROSTAGLANDIN SYNTHASE INHIBITOR; RECEPTOR SUBTYPE; RNA;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0029876321     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0046     Document Type: Article

References (48)

1. 2 receptor in PC12W cells. Reg Peptides 44: 207-213.
2. BRECHLER V, REICHLIN S, DE GASPARO M, BOTTARI SP, 1994. Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Receptors-Channels 2: 89-98.
3. CATALIOTO R, RENZETTI A, CRISCUOLI M, MIZRAHI J, SUBISSI A, 1994. Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity. Eur J Pharmacol 256: 93-97.
4. CHEN L, PRAKASH O, RE RN, 1993. The interaction of insulin and angiotensin II on the regulation of human neuroblastoma cell growth. Mol Chem Neuropath 18: 189-196.
5. CHIU AT, ROSCOE WA, MCCALL DE, TIMMERMANS PBMWM, 1991. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor 1: 133-140.
6. CHOMCZYNSKI P, SACCHI N, 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
7. DARIMONT C, VASSAUX G, AILHAUD G, NEGREL R, 1994. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin II. Endocrinology 135: 2030-2036.
8. 2) binding sites in R3T3 cells. Reg Peptides 44: 199-206.
9. DUDOV KP, PERRY RP, 1984. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene. Cell 37: 457-468.
10. DZAU VJ, RE R, 1994. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation 89:493-498.
11. FEUILLAN PP, MILLAN MA, AGUILERA G, 1993. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides. Reg Peptides 44: 159-169.
12. GIBBONS GH, PRATT RE, DZAU VJ, 1992. Vascular smooth muscle cell hypertrophy vs. hyperplasia. J Clin Invest 90: 456-461.
13. 3H]losartan in the rat liver. Biochem Pharmacol 46: 1643-1660.
14. IWAI N, INAGAMI T, 1992. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett 298: 257-260.
15. JAISWAL N, DIZ DI, TALLANT EA, KHOSLA MC, FERRARIO CM, 1991a. The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis. Am J Hypertens 4: 228-233.
16. JAISWAL N, TALLANT EA, DIZ DI, KHOSLA MC, FERRARIO CM, 1991b. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension 17: 1115-1120.
17. JAISWAL N, TALLANT EA, JAISWAL RK, DIZ DI, FERRARIO CM, 1993. Differential regulation ofprostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther 265: 664-673.
18. JANIAK P, PILLON A, PROST J, VILAINE J, 1992. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20: 737-745.
19. KAMBAYASHI Y, BARDHAN S, INAGAMI T, 1993a. Peptide growth factors markedly decrease the ligand binding of angiotensin subtype 2 receptor in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun 194: 478-482.
20. KAMBAYASHI Y, BARDHAN S, TAKAHASHI K, TSUZUKI S, INUI H, HAMAKUBO T, INAGAMI T, 1993b. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268: 24543-24546.
21. KIMES BW, BRANDT BL, 1976. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 98: 349-366.
22. KUNERT-RADEK J, STEPIEŃ H, KOMOROWSKI J, PAWLIKOWSKI M, 1994. Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors. Biochem Biophys Res Commun 198: 1034-1039.
23. 2. J Biol Chem 268: 20713-20716.
24. 2) binding sites in the rat pheochromocytoma PC12W cells. Eur J Pharmacol 227: 63-70.
25. LIBBY P, O'BRIEN KV, 1983. Culture of quiescent arterial smooth muscle cells in a defined serum-free media. J Cell Physiol 115: 217-223.
26. 2 (TP) receptors. Prostaglandins 44: 89-99.
27. LIU YJ, SHANKLEY NP, WELSH NJ, BLACK JW, 1992b. Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action. Br J Pharmacol 106: 233-241.
28. LOKUTA AJ, COOPER C, GAA ST, WANG HE, ROGERS TB, 1994. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. J Biol Chem 269: 4832-4838.
29. 1 receptors. Proc Nat Acad Sci 87: 6507-6511.
30. MATSUBARA H, KANASAKI M, MURASAWA S, TSUKAGUCHI Y, NIO Y, INADA M, 1994. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 93: 1592-1601.
31. MUKOYAMA M, NAKAJIMA M, HORIUCHI M, SASAMURA H, PRATT RE, DZAU VJ, 1993. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268: 24539-24542.
32. MULDOON LL, RODLAND KD, FORSYTHE ML, MAGUN BE, 1989. Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells. J Biol Chem 264: 8529-8536.
33. NAHMIAS C, CAZAUBON SM, BRIEND-SUTREN MM, LAZARD D, VILLAGEOIS P, STROSBERG AD, 1995. Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells. Biochem J 306: 87-92.
34. NIO Y, MATSUBARA H, MURASAWA S, KANASAKI M, INADA M, 1995. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95: 46-54.
35. REYNOLDS EE, DUBYAK GR, 1986. Agonist-induced calcium transients in cultured smooth muscle cells: measurements with fura-2 loaded monolayers. Biochem Biophys Res Commun 136: 927-934.
36. SECHI LA, GRIFFIN CA, SCHAMBELAN M, 1994. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 43: 1180-1184.
37. SHANAHAN CM, WEISSBERG PL, METCALFE JC, 1993. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73: 193-204.
38. 2 receptor populations in murine neuroblastoma N1E-115 cells. J Neurochem 62: 2106-2115.
39. STEINBERG MI, WIEST SA, PALKOWITZ AD, 1993. Nonpeptide angiotensin II receptor antagonists. Cardiovasc Drug Rev 11: 312-358.
40. STOLL M, STECKELINGS UM, PAUL M, BOTTARI SP, METZGER R, UNGER T, 1995. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657.
41. 2. Biochem Biophys Res Commun 198: 60-66.
42. VISWANATHAN M, TSUTSUMI K, CORREA FMA, SAAVEDRA JM, 1991. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 179: 1361-1367.
43. 2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens 11 [Suppl. 5]: S234-S235.
44. WU J, EDWARDS D, BERECEK KH, 1994. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril. Hypertension 23: 819-822.
45. ZAHRADKA P, YAU L, 1994. ADP-ribosylation and gene expression. Mol Cell Biochem 138: 91-98.
46. ZAHRADKA P, ELLIOT T, HOVLAND K, LARSON DE, SAWARD L, 1993. Repression of histone gene transcription in quiescent 3T6 fibroblasts. Eur J Biochem 127: 683-690.
47. ZAHRADKA P, HARRIS KD, TRIGGS-RAINE B, LAMONTAGNE G, LEBLANC N, 1995. PCR-based analysis of voltage-gated channels in vascular smooth muscle. Mol Cell Biochem 145: 39-44.
48. ZHANG J, PFAFFENDORF M, ZHANG JS, VAN ZWIETEN PA, 1994. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations. Eur J Pharmacol 252: 337-340.